Cargando…
Gambogenic acid exerts anticancer effects in cisplatin-resistant non-small cell lung cancer cells
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and the most common cause of mortality in patients with lung cancer. The efficacy of cisplatin-based chemotherapy in NSCLC is limited by drug resistance, therefore, the development of novel anticancer agents is required to ove...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003042/ https://www.ncbi.nlm.nih.gov/pubmed/31922223 http://dx.doi.org/10.3892/mmr.2020.10909 |